COVID Pill
-
U.S. pharmacists can now prescribe COVID pills. Canada should follow suit, experts sayThe Canadian Pharmacists Association says 'pharmacists in every jurisdiction' should be allowed to prescribe Paxlovid for COVID-19 following U.S. FDA's authorization on Wednesday.HealthJul 7, 2022
-
Isolate if you catch COVID again after taking Pfizer’s pill, U.S. CDC saysAlthough Pfizer says such incidents are rare, the U.S. CDC advises reinfected COVID patients to isolate for five days even after treatment.HealthMay 25, 2022
-
Who can get COVID-19 pill Paxlovid in New Brunswick?Eligibility for the pill is still narrower in New Brunswick than in some neighbouring provinces. It’s prescribed by primary care providers and available at pharmacies at no cost.HealthApr 23, 2022
![]()
-
Pfizer forecasts higher COVID-19 vaccine, pill sales in 2022, but analysts expected morePfizer raised the guidance on its anticipated vaccine and COVID-19 antiviral pill Paxlovid on Tuesday, but not as high as analysts had been expecting.HealthFeb 8, 2022
![]()
-
Pfizer’s COVID pill is in short supply. Should unvaccinated be prioritized?"Paxlovid is just yet another piece of the puzzle that helps us manage this illness in people who may be at more risk," said Dr. Gerald Evans of the new COVID-19 treatment.HealthJan 18, 2022
![]()
-
Paxlovid pills set to arrive in Saskatchewan this weekThe province stressed the availability of the novel treatments will be limited and that they are not a substitute for getting vaccinated.CanadaJan 18, 2022
![]()
-
Canada approved Paxlovid, Pfizer’s new oral COVID pill. What you need to knowAs Canada stares down an expected jump in hospitalizations, Paxlovid could play "an important role" in the fight against COVID-19, according to health officials.CanadaJan 17, 2022
![]()
-
Approval of Pfizer COVID-19 pills coming in 7-10 days: Health CanadaCanadian health leaders have been publicly calling for the medication to be approved. The pills prevent the virus that causes COVID-19 from reproducing within a patient's body.HealthJan 13, 2022
![]()
-
Merck’s antiviral COVID-19 pill approved by U.S. FDA for at-home useMerck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce COVID-19 hospitalizations and deaths by around 30 per cent.WorldDec 23, 2021
![]()
-
Pfizer to allow other companies to make its COVID-19 pillCOVID-19 vaccine maker Pfizer has agreed to grant a license for its antiviral pill to the Medicines Patent Pool, which would allow other companies to make the treatment.HealthNov 16, 2021
![]()
